No Data
No Data
Cosmos Pharmaceuticals, 7&I-HD, etc. (additional) Rating
Target stock price change code | Stock name | Securities company | Previous | After change | ------ | ------------- | ------------- | --------- | --------- | <2802> | Ajinomoto | GS | 6800 yen | 7000 yen | <2914> | JT | GS | 4400 yen | 4600 yen | <3349> | Cosmos Pharmaceutical | Mizuho
List of Cloud Breakout Stocks [Ichimoku Balance Table, List of Cloud Breakout Stocks]
List of stocks that are breaking through the clouds in the market: Code, Company name, closing price, leading span A, leading span B. Tokyo Stock Exchange Prime: <1813>, Fudote-Tetra, 2452, 2448.25, 2274.5; <1871>, P.S., 1026, 1016.25, 1015; <1898>, Seiko Tokyu, 1774, 1676.25, 1773. <1944>
U.S. Hematology Diagnostics Market Size, Share & Trends Analysis Report 2024-2030 Featuring Abbott, Beckman Coulter, Sysmex, Horiba, Bio-Rad, Siemens, Mindray and F. Hoffmann-La Roche Among Others
Sumitomo Riko, Shionogi, etc. (additional) rating.
Upgrade-Power Code | Stock Name | Securities Company | Previous | After changing | ------ | --------------- | ------------- | -------------- | -------------- | <2212> | Yamazaki Bread | GS | "Hold" | "Buy" | <4293> | Septeni HD | MSMUFG | "UnderW" | "Iko"
Sysmex America Announces Dan Zortman as New CEO
CHICAGO, July 9, 2024 /PRNewswire/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and information systems, today
Optim Research Memo (1): Achieving record sales and profits for the year ending March 2024 (1)
Optim <3694> is a venture company specializing in AI and IoT technologies. They aim to play a central role in the fourth industrial revolution by standardizing their main products, "Optimal Biz" and "OPTiM Cloud IoT OS". They have been developing technology with the goal of creating services that do not yet exist from the beginning, and they own many related patents (1,129 applications and 548 registrations as of March 2024).
No Data